Search
Menu
Home
HTB
2018
April
HTB
April 2018
Contents
Editorial
16 April 2018: vol 19 no 7: CROI 2018 part 3
In memory
In Memory: Professor David Cooper
Conference reports
CROI 2018: third reports
No increased risk of IRIS in people with low CD4 counts receiving raltegravir in the REALITY trial
Isoniazid preventive TB therapy in pregnancy and postpartum: recommendations now need to be re-evaluated
Efavirenz might decrease effectiveness of the vaginal contraceptive ring
Switch to TAF appears safe and effective in adolescents: similar PK to adults
Doubling raltegravir dose could overcome interaction with rifampicin in children aged 2 to 6
Twice-daily bictegravir does not overcome drug interaction with rifampicin
Reducing risk of myocardial infarction (MI) in HIV positive people
M184V mutation associated with increased risk of viral blip but not viral failure with 3TC-based dual therapy
HIV prevention and transmission
PrEP engagement workshops
On the web
Legal Aide – an app if arrested for personal drug possession
IAS reviews
TAGline Spring 2018
PDFs
16 April 2018: vol 19 no 7
HTB RSS
Early access
Future PrEP and new results from PURPOSE 1 and 2: does HIV exposure explain incident cases?
21 November 2024
Glasgow HIV Congress 2024
10 November 2024
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
Bipolar disorder in people living with HIV
1 November 2024
All early access reports
Current issues
November 2024
October 2024
September 2024
Back issues
Special report
HTB news: i-Base changes during 2024
1 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate